Home > Income Statement > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Revenue

    Back to Income Statement
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAXOSMITHKLINE PHARMACEUTICALS
Please provide your vote to see the results

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹3,822 Cr₹3,749 Cr₹3,454 Cr₹3,252 Cr₹3,278 Cr

What is the latest Revenue of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Revenue ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹3,822 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹3,822 Cr
Mar2025₹3,749 Cr
Mar2024₹3,454 Cr
Mar2023₹3,252 Cr
Mar2022₹3,278 Cr

How is Revenue of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2026 ₹3,822 Cr
1.93
Mar2025 ₹3,749 Cr
8.56
Mar2024 ₹3,454 Cr
6.21
Mar2023 ₹3,252 Cr
-0.80
Mar2022 ₹3,278 Cr -

Compare Revenue of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹41,518.2 Cr 2.2% 11% -25.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,924.0 Cr -0.3% 3.4% 12.7% Stock Analytics
DIVIS LABORATORIES ₹174,619.0 Cr -2.5% -1.2% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹156,450.0 Cr 2.4% 5.2% 47.2% Stock Analytics
CIPLA ₹118,361.0 Cr 2.2% 4.8% -3% Stock Analytics
DR REDDYS LABORATORIES ₹113,253.0 Cr 4.3% 4.1% 4.5% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

2.2%

11%

-25.7%

SENSEX

-0.8%

0.8%

-7.2%


You may also like the below Video Courses